Plaintiffs’ attorneys involved in the federal multidistrict litigation (MDL) for all Zantac cancer lawsuits filed throughout the federal court system have notified the Court that they only intend to move forward with expert support that establishes five different types of cancer may be caused by Zantac, including bladder cancer, esophageal cancer, gastric cancer, liver cancer…
As new Belviq cases continue to be filed on behalf of former users of the recalled weight loss drug who have now been diagnosed with cancer, a panel of federal judges convened on July 29th to consider whether to centralize and consolidate all lawsuits filed in U.S. District Courts nationwide. Consumers on Thursday urged the…
In the wake of a recent Belviq recall, which removed the controversial diet drug from the market after it was linked to a risk of cancer, a number of consumers and lawyers are likely to file class action lawsuits that seek medical monitoring, as well as individual injury lawsuits for those who have already developed…
Plaintiffs are pushing back against an attempt by generic drug manufacturers and repackagers to dismiss ranitidine class action lawsuits filed over the risk of cancer from high levels of the chemical byproduct found in all versions of the heartburn drug, which was more commonly known by the brand name Zantac. Over the past year, ranitidine…
